医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
BLTE · BELITE BIO, INC
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
BELITE BIO, INC（BLTE）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $32.1M；高管董事有效买入 —、有效卖出 —。最近申报 2026-10-05。
买入 Bought—
卖出 Sold$32.1M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-01 | Scholl Hendrik Peter Chief Medical Officer | 卖出 Sell | 500 | $165.32 | $83K | SEC |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer, Director | 卖出 Sell | 67,395 | $189.98 | $12.8M | SEC |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer, Director | 卖出 Sell | 100,435 | $190.00 | $19.1M | SEC |
| 2026-08-12 | Lin Yu-Hsin Chief Executive Officer, Director | 卖出 Sell | 365 | $180.35 | $66K | SEC |
| 2026-08-12 | Chuang Hao-Yuan Chief Financial Officer, Director | 卖出 Sell | 144 | $180.00 | $26K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-10-01 | Scholl Hendrik Peter Officer | 4,000 | $679K | 10b5-1 |
| 2026-08-12 | Lin Yu-Hsin CEO, Chairman | 126,800 | $22.5M | 10b5-1 |
| 2026-08-12 | Chuang Hao-Yuan Officer, Director | 93,800 | $16.7M | 10b5-1 |
内部人 Insiders
Scholl Hendrik Peter、Chuang Hao-Yuan、Lin Yu-Hsin